Literature DB >> 17376043

Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patients.

Li-Po Lee1, Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, Nei-Jen Hou, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Tong-Jong Chen, Ming-Lung Yu.   

Abstract

BACKGROUND: The aim of the present study was to compare the histological characteristics of livers between chronic hepatitis C (CHC) patients with and without hepatitis B virus (HBV) coinfection.
METHODS: A total of 336 CHC patients (male/female: 204/132, mean age: 46.1 +/- 11.7 years) were enrolled in the study; 32 patients (9.8%) were positive for hepatitis B surface antigen (HBsAg). The histological characteristics of livers were described according to the Knodell and Scheuer scoring system.
RESULTS: The proportion of non-intralobular necrosis (score 0) was significantly lower and the mean intralobular necrosis score was higher among CHC patients with HBV coinfection than those without coinfection (43.8% vs 64.5%; 0.84 +/- 1.05 vs 0.53 +/- 0.89). The epidemiological and virological parameters, and other histological scores (periportal necrosis, portal inflammation, total necroinflammation and fibrosis) were not significantly different between these two groups.
CONCLUSION: Chronic hepatitis C patients with HBV coinfection tend to have more severe intralobular necrosis than those with isolated HCV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376043     DOI: 10.1111/j.1440-1746.2006.04547.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  20 in total

Review 1.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

2.  Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.

Authors:  Carla S Coffin; Scott K Fung; Mang M Ma
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

Review 3.  Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis.

Authors:  Xian-Wan Jiang; Jian-Zhong Ye; Ya-Ting Li; Lan-Juan Li
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 4.  2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2018-08-10

Review 5.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 6.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

7.  KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2012-06-26

Review 8.  Hepatitis B virus and hepatitis C virus dual infection.

Authors:  Gaia Caccamo; Francesca Saffioti; Giovanni Raimondo
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

9.  Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.

Authors:  Gia L Tyson; Jennifer R Kramer; Zhigang Duan; Jessica A Davila; Peter A Richardson; Hashem B El-Serag
Journal:  Hepatology       Date:  2013-07-01       Impact factor: 17.425

10.  Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy.

Authors:  Yasuteru Kondo; Yoshiyuki Ueno; Masashi Ninomiya; Keiichi Tamai; Yasuhito Tanaka; Jun Inoue; Eiji Kakazu; Koju Kobayashi; Osamu Kimura; Masahito Miura; Takeshi Yamamoto; Tomoo Kobayashi; Takehiko Igarashi; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2012-05-16       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.